173 related articles for article (PubMed ID: 9467799)
1. Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment.
Ellinwood EH; Lee TH
NIDA Res Monogr; 1997; 175():192-207. PubMed ID: 9467799
[No Abstract] [Full Text] [Related]
2. Cognitive effects of cocaine and polydrug abuse.
Rosselli M; Ardila A
J Clin Exp Neuropsychol; 1996 Feb; 18(1):122-35. PubMed ID: 8926291
[TBL] [Abstract][Full Text] [Related]
3. Outcome measurement considerations: pharmacological treatments for substance abuse.
Moras K
NIDA Res Monogr; 1997; 175():118-36. PubMed ID: 9467795
[No Abstract] [Full Text] [Related]
4. Treatment effectiveness score as an outcome measure in clinical trials.
Ling W; Shoptaw S; Wesson D; Rawson RA; Compton M; Klett CJ
NIDA Res Monogr; 1997; 175():208-20. PubMed ID: 9467800
[No Abstract] [Full Text] [Related]
5. Abuse of cocaine with opioids: psychological aspects of treatment.
Kosten TR; Gawin FH; Rounsaville BJ; Kleber HD
NIDA Res Monogr; 1986; 67():278-82. PubMed ID: 3092078
[No Abstract] [Full Text] [Related]
6. Quantitative urine levels of cocaine and other substances of abuse.
Wilkins JN
NIDA Res Monogr; 1997; 175():235-52. PubMed ID: 9467802
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis.
Jones RT
NIDA Res Monogr; 1997; 175():221-34. PubMed ID: 9467801
[No Abstract] [Full Text] [Related]
8. The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence.
Cacciola JS; Alterman AI; O'Brien CP; McLellan AT
NIDA Res Monogr; 1997; 175():182-91. PubMed ID: 9467798
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
[TBL] [Abstract][Full Text] [Related]
10. Utility of the Cognitive Status Examination (CSE) for detection of neuropsychological impairment in substance abuse patients.
Gillen R; Kranzler H; Kadden R; Wiedenman M
NIDA Res Monogr; 1990; 105():595-6. PubMed ID: 1876134
[No Abstract] [Full Text] [Related]
11. Pharmacotherapy for adolescents with psychoactive substance use disorders.
Kaminer Y
NIDA Res Monogr; 1995; 156():291-324. PubMed ID: 8594475
[No Abstract] [Full Text] [Related]
12. Cognitive efficiency in stimulant abusers with and without alcohol dependence.
Lawton-Craddock A; Nixon SJ; Tivis R
Alcohol Clin Exp Res; 2003 Mar; 27(3):457-64. PubMed ID: 12658111
[TBL] [Abstract][Full Text] [Related]
13. Abstinence symptomatology and neuropsychological impairment in chronic cocaine abusers.
O'Malley SS; Gawin FH
NIDA Res Monogr; 1990; 101():179-90. PubMed ID: 2092215
[No Abstract] [Full Text] [Related]
14. Medications development at the National Institute on Drug Abuse: focus on cocaine.
Johnson DN; Vocci FJ
NIDA Res Monogr; 1993; 135():57-70. PubMed ID: 8289904
[TBL] [Abstract][Full Text] [Related]
15. Overview of potential treatment medications for cocaine dependence.
McCance EF
NIDA Res Monogr; 1997; 175():36-72. PubMed ID: 9467792
[No Abstract] [Full Text] [Related]
16. Sequential neuromotor examination of children with intrauterine drug exposure.
Belcher HM; Shapiro BK; Leppert M; Butz AM; Sellers S; Arch E; Kolodner K; Pulsifer M; Lears K; Kaufmann WE
Ann N Y Acad Sci; 1998 Jun; 846():362-4. PubMed ID: 9668425
[No Abstract] [Full Text] [Related]
17. Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research.
Kreek MJ
NIDA Res Monogr; 1997; 175():5-35. PubMed ID: 9467791
[No Abstract] [Full Text] [Related]
18. Major mental health issues: schizophrenia, cocaine abuse.
Alger I
Hosp Community Psychiatry; 1986 Sep; 37(9):871-2. PubMed ID: 3758969
[No Abstract] [Full Text] [Related]
19. Management of cocaine abuse and dependence.
Mendelson JH; Mello NK
N Engl J Med; 1996 Apr; 334(15):965-72. PubMed ID: 8596599
[No Abstract] [Full Text] [Related]
20. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
Verdejo-García AJ; López-Torrecillas F; Aguilar de Arcos F; Pérez-García M
Addict Behav; 2005 Jan; 30(1):89-101. PubMed ID: 15561451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
